Healthpeak Properties, Inc. (NYSE:DOC) Stock Position Raised by Keybank National Association OH

Keybank National Association OH increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 19.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,112,499 shares of the real estate investment trust's stock after buying an additional 178,009 shares during the period. Keybank National Association OH owned about 0.16% of Healthpeak Properties worth $22,495,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Mizuho Bank Ltd. bought a new stake in shares of Healthpeak Properties in the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Healthpeak Properties in the 4th quarter worth about $30,000. Future Financial Wealth Managment LLC bought a new stake in shares of Healthpeak Properties in the 1st quarter worth about $30,000. S.A. Mason LLC increased its position in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after purchasing an additional 925 shares during the last quarter. Finally, Covestor Ltd increased its position in shares of Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after purchasing an additional 1,152 shares during the last quarter. Institutional investors own 93.57% of the company's stock.

Insiders Place Their Bets

In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,777 shares of the company's stock in a transaction on Wednesday, May 28th. The shares were purchased at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Scott M. Brinker bought 2,750 shares of the company's stock in a transaction that occurred on Friday, May 9th. The stock was acquired at an average price of $17.39 per share, for a total transaction of $47,822.50. Following the completion of the acquisition, the chief executive officer directly owned 204,613 shares in the company, valued at approximately $3,558,220.07. This represents a 1.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 29,764 shares of company stock worth $521,909 over the last ninety days. Company insiders own 0.23% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on DOC shares. Wall Street Zen raised shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Sunday, June 29th. Wedbush lowered their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Evercore ISI lowered their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Finally, Scotiabank lowered their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $23.27.

Healthpeak Properties Stock Performance

Healthpeak Properties stock traded down $0.07 during midday trading on Friday, reaching $18.25. 5,546,828 shares of the stock traded hands, compared to its average volume of 5,331,883. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. The firm has a fifty day moving average price of $17.42 and a two-hundred day moving average price of $19.02. The firm has a market cap of $12.68 billion, a price-to-earnings ratio of 10.01, a PEG ratio of 2.08 and a beta of 1.03. Healthpeak Properties, Inc. has a fifty-two week low of $16.64 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. Healthpeak Properties's revenue was up 15.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.45 EPS. On average, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently announced a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties's payout ratio is 305.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.